Global /South Korea /Healthcare /Drug Manufacturers - General /131030

OPTUS Pharmaceutical Co., Ltd.

131030

• KRX: 131030 • Delayed

9,500KRW 1.2%

6.22 USD

As of 13 June 2026, OPTUS Pharmaceutical Co., Ltd. has a market cap of $110.23M USD, ranking #24852 globally and #1164 in South Korea. It ranks #2224 in the Healthcare sector, and #805 in the Drug Manufacturers - General industry.

Global Rank

24852

Country Rank

1164

Sector Rank

2224

Industry Rank

805

Key Stats

Market Cap

$110.23MUSD

167.64B KRW

Enterprise Value

$84.4MUSD

128.82B KRW

Revenue (TTM)

$57.31MUSD

87.16B KRW

EBITDA (TTM)

$8.9MUSD

13.58B KRW

Net Income (TTM)

$7.47MUSD

11.36B KRW

EBITDA Margin

16%

Profit Margin

13%

PE Ratio

13.0

PS Ratio

1.9

PB Ratio

1.0

EV/EBITDA

9.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dong-Hwa Han open_in_new

Employees

159

Founded

2002

Website

optuspharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.2%	-3.6%	-44%	18%	34%	38%	52%	29%	14%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	131030 (주)옵투스제약 ISIN: KR7131030009 Shares Out.: Shares Outstanding: 17.372M¹ Shares Float: 10.14M² TV: TradingView: KRX: 131030 SA: Stock Analysis: KRX: 131030 YF: Yahoo Finance: 131030.KS GF: Google Finance: KRX: 131030 BA: Barron's: 131030 MS: Morningstar: XKRX: 131030	9,500 KRW	TV: TradingView: KRX: 131030 SA: Stock Analysis: KRX: 131030 YF: Yahoo Finance: 131030.KS GF: Google Finance: KRX: 131030 BA: Barron's: 131030 MS: Morningstar: XKRX: 131030

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About OPTUS Pharmaceutical Co., Ltd.

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 8K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 6K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 5K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 4K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 4K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 691K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 496K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 327K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 292K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 262K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 249K%	20.5	Switzerland

chevron_leftBack